SAFETY OF FENOFIBRATE - UNITED-STATES AND WORLDWIDE EXPERIENCE

被引:45
作者
ROBERTS, WC
机构
关键词
D O I
10.1159/000174488
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:169 / 179
页数:11
相关论文
共 26 条
[1]   HYPERTRIGLYCERIDEMIA AND HYPERURICEMIA - EFFECTS OF 2 FIBRIC ACID-DERIVATIVES (BEZAFIBRATE AND FENOFIBRATE) IN A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
BASTOW, MD ;
DURRINGTON, PN ;
ISHOLA, M .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (03) :217-220
[2]  
BLANE GF, 1980, NOUV PRESSE MED, V9, P3737
[4]  
BLANE GF, 1987, DRUGS AFFECTING LIPI, P309
[5]   INFLUENCE OF FENOFIBRATE ON CELLULAR AND SUBCELLULAR LIVER STRUCTURE IN HYPERLIPIDEMIC PATIENTS [J].
BLUMCKE, S ;
SCHWARTZKOPFF, W ;
LOBECK, H ;
EDMONDSON, NA ;
PRENTICE, DE ;
BLANE, GF .
ATHEROSCLEROSIS, 1983, 46 (01) :105-116
[6]  
BOUCHERLE A, 1980, NOUV PRESSE MED, V9, P3721
[7]  
Brown W V, 1988, Hosp Pract (Off Ed), V23 Suppl 1, P31
[8]   FENOFIBRATE, A 3RD-GENERATION FIBRIC ACID-DERIVATIVE - INTRODUCTION [J].
BROWN, WV .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (5B) :1-2
[9]   EFFECTS OF FENOFIBRATE ON PLASMA-LIPIDS - DOUBLE-BLIND, MULTICENTER STUDY IN PATIENTS WITH TYPE-IIA OR TYPE-IIB HYPERLIPIDEMIA [J].
BROWN, WV ;
DUJOVNE, CA ;
FARQUHAR, JW ;
FELDMAN, EB ;
GRUNDY, SM ;
KNOPP, RH ;
LASSER, NL ;
MELLIES, MJ ;
PALMER, RH ;
SAMUEL, P ;
SCHONFELD, G ;
SUPERKO, HR .
ARTERIOSCLEROSIS, 1986, 6 (06) :670-678
[10]  
BROWN WV, 1987, AM J MED, V38, P85